vs
GLADSTONE COMMERCIAL CORP（GOOD）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是GLADSTONE COMMERCIAL CORP的1.7倍（$75.5M vs $43.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 16.3%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 10.3%）
格拉德斯通商业公司是一家上市房地产投资信托，主要在美国境内收购、持有及运营多元化的工业与商业地产组合，面向制造、物流、医疗、专业服务等领域的租户提供长期净租赁服务，核心客群为中小规模企业。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GOOD vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$43.5M
营收增速更快
PBYI
高出11.4%
16.3%
两年增速更快
PBYI
近两年复合增速
10.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.5M | $75.5M |
| 净利润 | $5.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 12.4% | — |
| 营收同比 | 16.3% | 27.7% |
| 净利润同比 | -25.1% | — |
| 每股收益（稀释后） | $0.05 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOODPBYI
| Q4 25 | $43.5M | $75.5M | ||
| Q3 25 | $40.8M | $54.5M | ||
| Q2 25 | $39.5M | $52.4M | ||
| Q1 25 | $37.5M | $46.0M | ||
| Q4 24 | $37.4M | $59.1M | ||
| Q3 24 | $39.2M | $80.5M | ||
| Q2 24 | $37.1M | $47.1M | ||
| Q1 24 | $35.7M | $43.8M |
净利润GOODPBYI
| Q4 25 | $5.4M | — | ||
| Q3 25 | $4.1M | $8.8M | ||
| Q2 25 | $4.6M | $5.9M | ||
| Q1 25 | $5.1M | $3.0M | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $11.7M | $20.3M | ||
| Q2 24 | $1.6M | $-4.5M | ||
| Q1 24 | $3.5M | $-4.8M |
毛利率GOODPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GOODPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率GOODPBYI
| Q4 25 | 12.4% | — | ||
| Q3 25 | 10.1% | 16.2% | ||
| Q2 25 | 11.7% | 11.2% | ||
| Q1 25 | 13.7% | 6.5% | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 29.8% | 25.2% | ||
| Q2 24 | 4.3% | -9.6% | ||
| Q1 24 | 9.9% | -11.0% |
每股收益（稀释后）GOODPBYI
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $0.03 | $0.12 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $0.10 | $0.40 | ||
| Q3 24 | $0.20 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.8M | $97.5M |
| 总债务越低越好 | $843.5M | $22.7M |
| 股东权益账面价值 | $171.8M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 4.91× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GOODPBYI
| Q4 25 | $10.8M | $97.5M | ||
| Q3 25 | $18.4M | $94.4M | ||
| Q2 25 | $11.7M | $96.0M | ||
| Q1 25 | $10.4M | $93.2M | ||
| Q4 24 | $11.0M | $101.0M | ||
| Q3 24 | $10.5M | $96.7M | ||
| Q2 24 | $10.4M | $96.8M | ||
| Q1 24 | $10.5M | $107.2M |
总债务GOODPBYI
| Q4 25 | $843.5M | $22.7M | ||
| Q3 25 | $843.3M | $34.0M | ||
| Q2 25 | $794.4M | $45.3M | ||
| Q1 25 | $740.7M | $56.7M | ||
| Q4 24 | $693.4M | $68.0M | ||
| Q3 24 | $692.6M | $79.3M | ||
| Q2 24 | $722.5M | $90.7M | ||
| Q1 24 | $719.4M | $102.0M |
股东权益GOODPBYI
| Q4 25 | $171.8M | $130.3M | ||
| Q3 25 | $184.8M | $115.3M | ||
| Q2 25 | $177.2M | $104.7M | ||
| Q1 25 | $183.2M | $97.1M | ||
| Q4 24 | $171.2M | $92.1M | ||
| Q3 24 | $168.9M | $71.1M | ||
| Q2 24 | $145.7M | $48.5M | ||
| Q1 24 | $147.3M | $51.0M |
总资产GOODPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比GOODPBYI
| Q4 25 | 4.91× | 0.17× | ||
| Q3 25 | 4.56× | 0.30× | ||
| Q2 25 | 4.48× | 0.43× | ||
| Q1 25 | 4.04× | 0.58× | ||
| Q4 24 | 4.05× | 0.74× | ||
| Q3 24 | 4.10× | 1.12× | ||
| Q2 24 | 4.96× | 1.87× | ||
| Q1 24 | 4.88× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $88.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 16.38× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流GOODPBYI
| Q4 25 | $88.2M | $14.4M | ||
| Q3 25 | $18.9M | $9.7M | ||
| Q2 25 | $35.8M | $14.1M | ||
| Q1 25 | $17.7M | $3.6M | ||
| Q4 24 | $57.0M | $15.6M | ||
| Q3 24 | $5.5M | $11.0M | ||
| Q2 24 | $13.6M | $1.0M | ||
| Q1 24 | $15.0M | $11.2M |
自由现金流GOODPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率GOODPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度GOODPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率GOODPBYI
| Q4 25 | 16.38× | — | ||
| Q3 25 | 4.57× | 1.10× | ||
| Q2 25 | 7.74× | 2.41× | ||
| Q1 25 | 3.44× | 1.21× | ||
| Q4 24 | 7.93× | — | ||
| Q3 24 | 0.47× | 0.54× | ||
| Q2 24 | 8.44× | — | ||
| Q1 24 | 4.26× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
